Entera Bio Earnings Estimates, EPS & Revenue | NASDAQ:ENTX

Comments

Entera Bio Ltd Earnings Estimates

ENTXNASDAQ

Trade with Public

$1.32

-0.07-5.04%

At close: Mar 12, 5:00 PM EST

$1.26

-0.06-4.55%

After Hours: 7:21 PM EST

Overview NewsEarningsOptions Analyst Ratings Insider Trades Short Interest Stock Report

Entera Bio Earnings Estimates, EPS & Revenue | NASDAQ:ENTX

Entera Bio (ENTX) is scheduled to report Q4 earnings on March 27, 2026. Analysts estimate EPS of $-0.09 and quarterly revenue of N/A.

In the most recent quarter (Q3), Entera Bio reported EPS of $-0.07, beating estimates of $-0.09 by 0.22%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Over the last 4 quarters, Entera Bio has averaged an EPS surprise of 0.42% and a revenue surprise of 1.02%.

Earnings Date

Mar 27

EPS Estimate

$-0.090

Quarterly Revenue Estimate

–

Annual Revenue
(as of Sep 30)

$124.00K

Entera Bio Earnings History

Analyze the earnings history of Entera Bio using advanced sorting and filters.

Entera Bio (ENTX) Earnings Per Share

The chart below shows Entera Bio's reported EPS compared to analyst estimates over recent quarters.

Entera Bio (ENTX) Revenue

The chart below shows Entera Bio's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Entera Bio (NASDAQ:ENTX) reporting earnings?

Entera Bio (ENTX) is scheduled to report earnings on May 8, 2026. The last reported earnings were for reported on November 14, 2025 for Q3.

What were the latest earnings per share (EPS) for Entera Bio (NASDAQ:ENTX)?

The Actual EPS was $-0.07, which beat the estimate of $-0.09.

What were Entera Bio’s (NASDAQ:ENTX) revenues?

The Actual Revenue was $0.00, which hit the estimate of $0.00.

People Also Watch

Coeptis Therapeutics Holdings Inc

OSTX

TScan Therapeutics Inc

Plus Therapeutics Inc

NASDAQ:PSTV

$0.29

-1.62%

Entera Bio Earnings Estimates, EPS & Revenue | NASDAQ:ENTX

Entera Bio (ENTX) is scheduled to report Q4 earnings on March 27, 2026. Analysts estimate EPS of $-0.09 and quarterly revenue of N/A.

In the most recent quarter (Q3), Entera Bio reported EPS of $-0.07, beating estimates of $-0.09 by 0.22%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Over the last 4 quarters, Entera Bio has averaged an EPS surprise of 0.42% and a revenue surprise of 1.02%.

Earnings Date

Mar 27

EPS Estimate

$-0.090

Quarterly Revenue Estimate

–

Annual Revenue
(as of Sep 30)

$124.00K